Related Experiment Video
Updated: Aug 8, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
The superoxide scavenger TEMPOL induces urokinase receptor (uPAR) expression in human prostate cancer cells
Danielle Lejeune1, Mohammad Hasanuzzaman, Amanda Pitcock
1LSU Department of Comparative Biomedical Sciences, Louisiana State University, Baton Rouge, LA 70803, USA. DLeJeune@vetmed.lsu.edu
Abstract:
There is little understanding of the effect that reactive oxygen metabolites have on cellular behavior during the processes of invasion and metastasis. These oxygen metabolites could interact with a number of targets modulating their function such as enzymes involved in basement membrane dissolution, adhesion molecules involved in motility or receptors involved in proliferation. We investigated the effect of increased scavenging of superoxide anions on the expression of the urokinase receptor (uPAR) in PC-3M human prostate cancer cells. Urokinase receptor is a GPI-linked cell surface molecule which mediates multiple functions including adhesion, proliferation and pericellular proteolysis. Addition of the superoxide scavenger 4-hydroxy-2,2,6,6-tetramethylpiperidinyloxy (TEMPOL) to PC-3M cultures stimulated expression of uPAR protein peaking between 48 and 72 hours. Cell surface expression of the uPAR was also increased. Surprisingly, uPAR transcript levels increased only slightly and this mild increase did not coincide with the striking degree of protein increase. This disparity indicates that the TEMPOL effect on uPAR occurs through a post-transcriptional mechanism. TEMPOL presence in PC-3M cultures reduced intracellular superoxide-type species by 75% as assayed by NBT dye conversion; however this reduction significantly diminished within hours following TEMPOL removal. The time gap between TEMPOL treatment and peak uPAR protein expression suggests that reduction of reactive oxygen metabolites in prostate cancer cells initiates a multistep pathway which requires several hours to culminate in uPAR induction. These findings reveal a novel pathway for uPAR regulation involving reactive oxygens such as superoxide anion.
Insights
Reducing superoxide anions with TEMPOL increases urokinase receptor (uPAR) protein in prostate cancer cells. This suggests a novel post-transcriptional pathway regulating uPAR expression via reactive oxygen species.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Reactive oxygen metabolites influence cellular functions critical for cancer invasion and metastasis.
- The role of reactive oxygen species (ROS) in regulating key molecules like urokinase receptor (uPAR) is not well understood.
- uPAR is a cell surface receptor involved in cancer cell adhesion, motility, proliferation, and matrix degradation.
Purpose of the Study:
- To investigate the effect of superoxide anion scavenging on uPAR expression in PC-3M human prostate cancer cells.
- To elucidate the mechanism by which superoxide anion levels influence uPAR expression.
- To explore potential therapeutic targets related to ROS and uPAR in prostate cancer.
Main Methods:
- PC-3M prostate cancer cells were treated with the superoxide scavenger TEMPOL.
- uPAR protein and transcript levels were quantified using various assays.
- Intracellular superoxide levels were measured using NBT dye conversion.
- Cell surface expression of uPAR was assessed.
Main Results:
- TEMPOL treatment significantly increased uPAR protein expression, peaking between 48 and 72 hours.
- Cell surface expression of uPAR also increased following TEMPOL treatment.
- uPAR transcript levels showed only a slight increase, suggesting post-transcriptional regulation.
- TEMPOL effectively reduced intracellular superoxide levels, but this effect was transient upon removal.
Conclusions:
- Superoxide anion reduction by TEMPOL induces a post-transcriptional increase in uPAR protein in prostate cancer cells.
- This indicates a novel regulatory pathway for uPAR involving reactive oxygen species.
- Understanding this pathway may offer new strategies for targeting prostate cancer metastasis.
More Related Videos
09:28Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Published on: May 12, 2019
06:54MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013